Stanford researchers used artificial intelligence to uncover BRP, a natural molecule that curbs appetite in animals without many of semaglutide's side effects.
What if the cure for hunger had been hiding in plain sight, tucked inside our own biology? Scientists at Stanford Medicine now think they have found a candidate. It is called BRP, and it is a naturally occurring molecule that, in early animal tests, suppressed appetite and promoted fat loss in much the same way as semaglutide, the active ingredient in Ozempic. How did they find it?
They did not wander through a lab with a pipette and a lucky guess. Artificial intelligence combed through thousands of possible biological compounds, flagging the ones worth a closer look. BRP rose to the top. Algorithms, it seems, can notice patterns in biology that human researchers might spend decades missing.
The real surprise is where BRP works. Semaglutide imitates a hormone called GLP-1, and GLP-1 receptors are scattered across the brain, gut, pancreas and other tissues. That helps explain the drug's wide reach, from slowed digestion to lower blood sugar, and perhaps its unpleasant side effects: nausea, constipation and substantial muscle loss. BRP appears to be more selective.